SKI Market

Indian Indices

Nifty

25,239.10 169.90
(0.68%)

Sensex

82,380.69 594.95
( 0.73%)

Bank Nifty

55,147.60 259.75
( 0.47%)

Nifty IT

36,212.15 310.00
( 0.86%)

Global Indices

Nasdaq

45,773.62 130.84
(-0.29%)

Dow Jones

6,626.82 -9.46
(-0.14%)

Hang Seng

44,932.94 164.82
(0.37%)

Nikkei 225

9,195.66 -81.37
(-0.88%)

Forex

USD-INR

88.27 0.00
(0.00%)

EUR-INR

103.57 0.18
(0.18%)

GBP-INR

119.65 0.10
(0.08%)

JPY-INR

0.60 0.00
(-0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

101.444166

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

77.59

386496.87

EPS(TTM)

Face Value()

Div & Yield %

20.76

0.99

Back

Tulsyan NEC reports consolidated net loss of Rs 10.25 crore in the June 2025 quarter

Aug 14,2025

Net loss of Tulsyan NEC reported to Rs 10.25 crore in the quarter ended June 2025 as against net profit of Rs 0.58 crore during the previous quarter ended June 2024. Sales declined 6.53% to Rs 257.30 crore in the quarter ended June 2025 as against Rs 275.28 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	257.30	275.28	-7
OPM %	4.87	5.50	-
PBDT	-4.51	6.72	PL
PBT	-10.25	0.58	PL
NP	-10.25	0.58	PL

25,239.10 169.90 (0.68%)

82,380.69 594.95 ( 0.73%)

55,147.60 259.75 ( 0.47%)

36,212.15 310.00 ( 0.86%)

45,773.62 130.84 (-0.29%)

6,626.82 -9.46 (-0.14%)

44,932.94 164.82 (0.37%)

9,195.66 -81.37 (-0.88%)

88.27 0.00 (0.00%)

103.57 0.18 (0.18%)

119.65 0.10 (0.08%)

0.60 0.00 (-0.17%)